[196 Pages Report] The Contraceptive Pills Market size was estimated at USD 19.53 billion in 2023 and expected to reach USD 20.76 billion in 2024, at a CAGR 6.46% to reach USD 30.27 billion by 2030.
Contraceptive pills are oral medications that contain synthetic hormones designed to regulate a woman's menstrual cycle and prevent unintended pregnancy. These pharmaceutical products primarily function by inhibiting ovulation, altering the cervical mucus to restrict sperm passage, and modifying the endometrial lining to minimize implantation of a fertilized egg. The growing awareness about family planning methods among different age groups and cultures has increase the demand for safe and effective contraceptives. However, the presence of alternative contraceptive methods or substandard products in the market limits consumers' utilization of contraceptive pills. Nevertheless, developing new formulations that offer improved efficacy and fewer side effects is expected to create potential opportunities for the contraceptive pills market.
In the Americas region, the contraceptive pills market is growing owing to widespread awareness campaigns, government support, and technological advancements from manufacturers for new contraceptive pill composition. According to the National Library of Medicine (NLM), Approximately 25% of women in the U.S. aged 15-44 currently use contraception pills as their method of choice. In the European region, public health programs promoting family planning education and affordable prices have gained popularity for the use of contraceptive pills. The Asia Pacific region showcases growth prospects for the market in the face of larger population economies such as China & India, creating demand for affordable contraceptive pills. Further, many emerging & developing countries create an opportunistic landscape for the market through the adoption of family planning education & awareness programs.
The combination pill is a widely used oral contraceptive that contains estrogen and progestin hormones and works by preventing ovulation, thickening cervical mucus to obstruct sperm entry, and thinning the endometrial lining to impede implantation. It addresses various needs such as menstrual cycle regulation, reduction of period pain, acne management, and prevention of ovarian cysts. Continuous or extended-cycle contraceptive pills are designed to reduce or eliminate periods by prolonging the active hormone phase beyond the typical 21-day cycle. This option caters to those who desire lesser menstruation frequency due to conditions such as endometriosis or personal preference. The progesterone-only pill, also known as the mini-pill, contains only progestin hormone and is suitable for those who cannot tolerate estrogen due to medical reasons or breastfeeding. This pill primarily works by thickening cervical mucus and thinning the endometrial lining.
In the age group of 15 to 24, contraceptive pills are primarily used to prevent unwanted pregnancies and manage hormonal imbalances such as polycystic ovary syndrome (PCOS) and dysmenorrhea; for women aged between 25 to 34 years old, contraceptive pill usage is driven by family planning needs and maintaining menstrual regularity. Women in this age group prefer contraceptives that provide additional benefits, such as minimizing premenstrual symptoms and improving skin health. Women in the 35 to 44 age bracket focus on long-term contraception methods, especially if they have completed their families or do not wish to conceive. In the age group of 45 years and above, contraceptive pills are less commonly used due to the decline in fertility with age. However, some women use low-dose combined oral contraceptives (COC) for hormonal balance during perimenopause.
Offline distribution includes channels such as pharmacies, clinics, hospitals, and public health centers. They cater to individuals with limited access to online resources, require immediate medication, or prefer face-to-face consultations with healthcare professionals. However, it may need more privacy and personalization than its digital counterpart. The expansion of digital platforms has led to a surge in online sales channels for contraceptive pills. This includes e-commerce websites, telemedicine platforms, and online pharmacies. The ability to compare prices from different providers also proves advantageous for budget-conscious buyers. The potential drawback lies in the delay between purchase and delivery of the medication, which can be disadvantageous in time-sensitive situations.
Oral contraceptive pills (OCPs) are a commonly preferred form of hormonal contraception worldwide. They contain synthetic estrogens and progestins that prevent ovulation, regulate the menstrual cycle, and reduce the risk of unplanned pregnancies. OCPs are popular due to their ease of use, non-invasive nature, and effectiveness when taken as prescribed. Vaginal contraceptives offer alternative options for those who may not prefer or tolerate oral contraception. The primary form of vaginal contraception is the contraceptive ring, which provides the same level of effectiveness as OCPs while reducing user error due to its once-a-month application.
The market dynamics represent an ever-changing landscape of the Contraceptive Pills Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Contraceptive Pills Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Contraceptive Pills Market.
The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Contraceptive Pills Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.
The value chain of the Contraceptive Pills Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.
The pricing analysis comprehensively evaluates how a product or service is priced within the Contraceptive Pills Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Contraceptive Pills Market.
The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Contraceptive Pills Market.
The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Contraceptive Pills Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.
The trade analysis of the Contraceptive Pills Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.
The regulatory framework analysis for the Contraceptive Pills Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Contraceptive Pills Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Contraceptive Pills Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Richter and Mithra sign supply agreement for production of API for combined oral contraceptive Estelle and Donesta
Gedeon Richter Plc and Mithra have entered into a binding supply agreement for the API of Estelle and Donesta. These two products are commonly used for contraception and post-menopausal symptoms. The collaboration with Richter strengthens Mithra's partnership and contributes to the expansion and enhancement of its manufacturing capabilities. Additionally, it provides Mithra with a reliable and attractive source of E4 native estrogen. [Published On: 2023-08-08]
FDA approves first nonprescription daily oral contraceptive
Food and Drug Administration (FDA) of U.S. approved Opill (norgestrel) as an over-the-counter daily oral contraceptive. The availability of nonprescription Opill is expected to reduce barriers to access for contraception, ultimately decreasing unwanted pregnancies and their potential negative impacts. Opill has been proven to be safe and effective in preventing pregnancy. [Published On: 2023-07-13]
Gedeon Richter announces availability of oral contraception Drovelis
Gedeon Richter announced the availability of Drovelis (E4/DRSP), a combined oral contraceptive in the UK. This marks the first time that a contraceptive tablet utilizing this specific combination of hormones has been made accessible through the NHS in England. The decision to introduce Drovelis follows positive results obtained from phase 3 randomized control trials conducted in Europe. [Published On: 2022-10-20]
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Contraceptive Pills Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
The report delves into recent significant developments in the Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Johnson & Johnson Services, Inc., Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Mayne Pharma Group Limited, Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Teva Pharmaceuticals, Viatris Inc., and Xiromed, LLC.
This research report categorizes the Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product
- Combination Pill
- Continuous/Extended Pill
- Progesterone Pill
- Age Group
- 15-24
- 25-34
- 35-44
- 45 and Above
- Route of Administration
- Oral
- Viginal
- Distribution
- Offline
- Online
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
- Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
- Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
- Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
- Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
- Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.
- What is the current market size and projected growth?
- Which products, segments, applications, and regions offer promising investment opportunities?
- What are the prevailing technology trends and regulatory frameworks?
- What is the market share and positioning of the leading vendors?
- What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
- Preface
- Research Methodology
- Executive Summary
- Market Overview
- Market Insights
- Contraceptive Pills Market, by Product
- Contraceptive Pills Market, by Age Group
- Contraceptive Pills Market, by Route of Administration
- Contraceptive Pills Market, by Distribution
- Americas Contraceptive Pills Market
- Asia-Pacific Contraceptive Pills Market
- Europe, Middle East & Africa Contraceptive Pills Market
- Competitive Landscape
- Competitive Portfolio
- List of Figures [Total: 24]
- List of Tables [Total: 374]
- List of Companies Mentioned [Total: 26]
One of the main advantages of purchasing contraceptive pills online is convenience. With online channels, women are no longer limited to pharmacy hours or location; they can purchase their preferred contraceptive pills at any time, from anywhere. This means you can discreetly order them from your home or workplace without worrying about anyone else knowing your business. Additionally, online channels provide more options for brands and types of contraceptive pills, giving women a wider range of choices.
Another advantage of purchasing contraceptive pills online is comparing prices and finding deals. Shopping online allows women to look at different websites and compare prices, which can often lead to savings on the cost of the pills. Many online channels also offer discounts and promotions that can save women even more money. So not only is buying online more convenient, but it can also save you money.
When shopping online, it's important to make sure that the website you are using is legitimate and safe. Look for trusted online pharmacies that are licensed and follow regulations for the sale of medications. You can also check for online reviews of the website to see what other customers have experienced. Ensuring you use a reliable site will give you peace of mind that you are purchasing safe and effective contraceptive pills.
Online channels often provide helpful resources and information if you are uncertain about which contraceptive pills to purchase. Reading product descriptions and customer reviews can give you a better idea of what to expect from the pills. You can also browse through FAQs and articles that provide information on the different types of contraceptive pills, how they work, and how to use them. This can be especially helpful for women who are new to using contraception or who want to switch to a different method.
When purchasing contraceptive pills online, it's important to consider shipping times and costs. Make sure to factor in the time it will take for the pills to arrive and plan accordingly. Additionally, consider if there are any shipping fees or minimum order requirements. Make sure you read the website's shipping policy and have a clear understanding of what to expect.
With the availability of contraceptive pills on online channels, buying these pills has become more convenient for women. Online channels not only provide a wider range of options, but they also save women time and money. However, ensuring the website is trustworthy and provides helpful resources and information before purchasing is important. Following these tips, women can safely and easily purchase contraceptive pills online.
- How big is the Contraceptive Pills Market?
- What is the Contraceptive Pills Market growth?
- When do I get the report?
- In what format does this report get delivered to me?
- How long has 360iResearch been around?
- What if I have a question about your reports?
- Can I share this report with my team?
- Can I use your research in my presentation?